LobbyingCommand Medical Products lobbying by quarter
Command Medical Products's latest lobbying report covers Q4 2025, at $20K. The four quarters Q4 2025–Q3 2026 total $20K. Its first report covers Q4 2025; the issues it reports most are Trade (Domestic & Foreign).
Command Medical Products
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $20K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2025 | $20K | 1 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Trade$20K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE1 reports
- U.S. Trade Representative (USTR)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Akin Gump Strauss Hauer & Feld | $20K | 1 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 01/20for Q4 2025 | Akin Gump Strauss Hauer & Feld | $20K |
| 01/05for Q4 2025 | Akin Gump Strauss Hauer & Feld | Under $5,000 |